Roles of microRNAs in Hepatitis C Virus Replication and Pathogenesis

Viruses. 2022 Aug 15;14(8):1776. doi: 10.3390/v14081776.

Abstract

Hepatitis C virus (HCV) infection is associated with the development of chronic liver diseases, e.g., fibrosis, cirrhosis, even hepatocellular carcinoma, and/or extra-hepatic diseases such as diabetes. As an obligatory intracellular pathogen, HCV absolutely relies on host cells to propagate and is able to modulate host cellular factors in favor of its replication. Indeed, lots of cellular factors, including microRNAs (miRNAs), have been identified to be dysregulated during HCV infection. MiRNAs are small noncoding RNAs that regulate protein synthesis of their targeting mRNAs at the post-transcriptional level, usually by suppressing their target gene expression. The miRNAs dysregulated during HCV infection could directly or indirectly modulate HCV replication and/or induce liver diseases. Regulatory mechanisms of various miRNAs in HCV replication and pathogenesis have been characterized. Some dysregulated miRNAs have been considered as the biomarkers for the detection of HCV infection and/or HCV-related diseases. In this review, we intend to briefly summarize the identified miRNAs functioning at HCV replication and pathogenesis, focusing on the recent developments.

Keywords: biomarker; hepatitis C virus; microRNAs; pathogenesis; replication.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Hepatocellular*
  • Hepacivirus / physiology
  • Hepatitis C*
  • Host-Pathogen Interactions
  • Humans
  • Liver Neoplasms*
  • MicroRNAs* / genetics
  • MicroRNAs* / metabolism
  • Virus Replication

Substances

  • MicroRNAs

Grants and funding

This research and APC were funded by the Ministry of Science and Technology, R.O.C., grant number MOST 109-2320-B-320-011-MY3 and Tzu Chi University, grant number TCIRP106001-04Y3 and TCIRP106001-02Y3.